Maximising the potential of neuroimmunology
- PMID: 32201255
- PMCID: PMC8353661
- DOI: 10.1016/j.bbi.2020.03.010
Maximising the potential of neuroimmunology
Abstract
Technological developments in recent years have led to a surge in advances in neuroimmunology, making real progress towards improving human health. With the scale of the challenges ahead, realising this potential requires a collaborative effort. The neuroscience, immunology and wider scientific community, both academia and industry, must come together to pool together ideas, experiences and resources.
Copyright © 2020. Published by Elsevier Inc.
References
-
- Landtblom A.M. The first case history of multiple sclerosis: Augustus d'Este (1794–1848) Neurol. Sci. 2010;31(1):29–33. - PubMed
-
- Pettinelli C.B., McFarlin D.E. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J. Immunol. 1981;127(4):1420–1423. - PubMed
-
- Lindstrom J.M. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976;26(11):1054–1059. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources